Radiation
Side-Effects
RT 21Gy
RT 30Gy
(N = 166) (N = 163)
Acute (£ 90 days)
CTC I° 36 (22%) 29 (18%)
CTC II° 8 ( 5%) 9 ( 6%) n.s.
(N = 166) (N = 163)
Acute (£ 90 days)
CTC I° 36 (22%) 29 (18%)
CTC II° 8 ( 5%) 9 ( 6%) n.s.
Chronic (> 1
yr.)
at 1 year: 8 ( 5%) 18 (11%)
at 3 years: 19 (11%) 22 (12%) n.s.
at 1 year: 8 ( 5%) 18 (11%)
at 3 years: 19 (11%) 22 (12%) n.s.
( final evaluation August 31, 2006 )
Noninvasive Therapy of M.
Dupuytren
Noninvasive Therapy of M.
Dupuytren
